Adam Koppel - Insider Trading & Ownership

Entity
Individual
Location
C/O Brookside Capital, Llc, John Hancock Tower, 200 Clarendon St, Boston, MA
Summary
The estimated net worth of Adam Koppel is at least $22.4M dollars as of August 5, 2024. Adam Koppel is the Director, 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $22.3M. Adam Koppel is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $88.3K.
All Insider Reports
All Insider Reports

Ownership of Adam Koppel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SLDB Solid Biosciences Inc. Director, 10%+ Owner $22.3M Jan 11, 2024
FHTX Foghorn Therapeutics Inc. Director $88.3K Jun 26, 2024
CERE Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner $0 Aug 1, 2024
APTX Aptinyx Inc. Director, 10%+ Owner May 26, 2022
DRNA Dicerna Pharmaceuticals Inc Director Dec 28, 2021

Insider Transactions Reported by Adam Koppel:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.